Liliana E. Pezzin, PhD, JD
Professor and Interim Director, Epidemiology & Social Sciences; Executive Director, Collaborative for Healthcare Delivery Science
Locations
- General Internal Medicine
Contact Information
Biography
Research Interests
Much of Dr. Pezzin’s research effort focuses on issues related to long-term care, aging and disability, with special emphasis on the interplay between public policy and family behavior. She recently concluded work as principal investigator on an NIA-funded grant examining the relationship between state long-term care policies and living and care arrangements of elderly persons, and as the co-principal investigator on another NIA-funded study developing game theoretical models of family long-term care decisions.
Her outcomes research portfolio includes analyses of the effects of patterns of breast cancer care on disease recurrence, mortality, quality of life and economic well-being; analyses of the relationship between guideline adherence, processes of care and outcomes in electrodiagnostic medicine; and two randomized controlled trials of behavioral interventions designed to (i) improve blood pressure control and (ii) self-management and reduce adverse events secondary to complex medication regimens among home health patients. Dr. Pezzin's research projects are funded by NCI, VA-HSR&D, NHLBI and AHRQ, respectively.
Publications
-
(Bickell NA, Nattinger AB, McGinley EL, Schymura MJ, Laud PW, Pezzin LE.) J Clin Oncol. 2024 Sep 30:JCO2302638 PMID: 39348624 09/30/2024
-
Age-Based Heuristics Bias Treatment of Displaced Femoral Neck Fractures in the Elderly.
(Edelstein AI, Tanenbaum JT, McGinley EL, Dillingham TR, Pezzin LE.) Arthroplast Today. 2024 Jun;27:101356 PMID: 38524153 PMCID: PMC10958215 03/25/2024
-
(Abramoff BA, Hentschel C, Dillingham IA, Dillingham T, Baraniecki-Zwil G, Williams A, Pezzin LE.) PM R. 2024 Jun;16(6):553-562 PMID: 38145343 PMCID: PMC11189756 12/25/2023
-
Timing and co-occurrence of symptoms prior to a diagnosis of light chain (AL) amyloidosis.
(Singh A, Szabo A, Lian Q, Pezzin L, Sparapani R, D'Souza A.) Blood Cancer J. 2024 May 26;14(1):61 PMID: 38796476 PMCID: PMC11127981 SCOPUS ID: 2-s2.0-85194268737 05/26/2024
-
(McLarney M, Fergestrom N, Zheng J, Pezzin LE.) PM R. 2024 May;16(5):441-448 PMID: 38129994 12/22/2023
-
(Dong Y, Hanson R, Penlesky AC, Nattinger AB, Heinrich TW, Pezzin LE.) WMJ. 2023 Dec;122(5):319-324 PMID: 38180917 SCOPUS ID: 2-s2.0-85181629574 01/05/2024
-
Widening demographic gaps in CAR-T therapy utilization for multiple myeloma in the United States.
(Lin M, Estrada-Merly N, Eapen M, Zamora AE, Pezzin LE, Winn AN, Philip J, Schinke C, Drobyski WR, Anderson LD Jr, D'Souza A.) Bone Marrow Transplant. 2023 Dec;58(12):1400-1402 PMID: 37673983 SCOPUS ID: 2-s2.0-85170080925 09/07/2023
-
(Edelstein AI, Dillingham TR, McGinley EL, Pezzin LE.) J Bone Joint Surg Am. 2023 Nov 01;105(21):1695-1702 PMID: 37678258 PMCID: PMC10609704 SCOPUS ID: 2-s2.0-85175741071 09/08/2023
-
Centralization of Initial Care and Improved Survival of Poor Patients With Breast Cancer.
(Nattinger AB, Bickell NA, Schymura MJ, Laud P, McGinley EL, Fergestrom N, Pezzin LE.) J Clin Oncol. 2023 Apr 10;41(11):2067-2075 PMID: 36603178 PMCID: PMC10419674 SCOPUS ID: 2-s2.0-85152169276 01/06/2023
-
Medication delivery factors and adjuvant endocrine therapy adherence in breast cancer.
(Neuner JM, Fergestrom N, Pezzin LE, Laud PW, Ruddy KJ, Winn AN.) Breast Cancer Res Treat. 2023 Jan;197(1):223-233 PMID: 36357711 SCOPUS ID: 2-s2.0-85141681578 11/11/2022
-
(Abramoff BA, Dillingham TR, Brown LA, Caldera F, Caldwell KM, McLarney M, McGinley EL, Pezzin LE.) Arch Phys Med Rehabil. 2023 Jan;104(1):11-17 PMID: 36202227 PMCID: PMC9529350 SCOPUS ID: 2-s2.0-85142481978 10/07/2022